Literature DB >> 22419672

Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis.

H Roshanisefat1, S Bahmanyar, J Hillert, T Olsson, S Montgomery.   

Abstract

BACKGROUND: Comorbid inflammatory conditions in multiple sclerosis (MS) patients suggest shared risks with MS.
OBJECTIVE: To estimate if the risk of immune-mediated disease in MS patients and their parents is increased.
METHODS: Swedish register data were analysed using Cox regression to estimate immune-mediated disease risk among 11284 fathers and 12006 mothers of MS patients, compared with 123158 fathers and 129409 mothers of index subjects without MS. Similar analyses were conducted among 20276 index subjects with MS and 203951 without.
RESULTS: Parents of patients with MS did not have a significantly altered immune-mediated disease risk. Patients with MS had a consistently raised risk for several immune-mediated diseases: ulcerative colitis, Crohn's disease, type 1 diabetes, psoriasis, polyarthritis nodosa and pemphigoid. The risk was more pronounced for diseases diagnosed subsequent to MS onset.
CONCLUSION: The increased occurrence of other immune-mediated diseases in MS patients may not be due to shared genetic factors and surveillance bias is likely to be the main or possibly the entire explanation. If not entirely explained by surveillance bias, a modestly raised occurrence of comorbid diseases may be due to shared environmental risks or factors related to MS disease characteristics.

Entities:  

Mesh:

Year:  2012        PMID: 22419672     DOI: 10.1177/1352458512438240

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  16 in total

Review 1.  Lifestyle and Environmental Factors in Multiple Sclerosis.

Authors:  Lars Alfredsson; Tomas Olsson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 2.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

3.  Breakdown of multiple sclerosis genetics to identify an integrated disease network and potential variant mechanisms.

Authors:  C Joy Shepard; Sara G Cline; David Hinds; Seyedehameneh Jahanbakhsh; Jeremy W Prokop
Journal:  Physiol Genomics       Date:  2019-09-04       Impact factor: 3.107

Review 4.  Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis.

Authors:  Maria Kosmidou; Aristeidis H Katsanos; Konstantinos H Katsanos; Athanassios P Kyritsis; Georgios Tsivgoulis; Dimitrios Christodoulou; Sotirios Giannopoulos
Journal:  J Neurol       Date:  2016-11-22       Impact factor: 4.849

5.  Comorbidities at multiple sclerosis diagnosis.

Authors:  Agnès Fromont; Christine Binquet; Fabien Rollot; Romain Despalins; Alain Weill; Laurence Clerc; Claire Bonithon-Kopp; Thibault Moreau
Journal:  J Neurol       Date:  2013-08-02       Impact factor: 4.849

6.  Gene-Gene Interaction between LCE and CLEC16A Increases the Risk of Psoriasis in a Chinese Population.

Authors:  Jianbo Wang; Yantao Ding; Xing Fan; Xianbo Zuo; Wen Wang; Hui Cheng; Ping Li; Liangdan Sun; Sen Yang; Xuejun Zhang
Journal:  Ann Dermatol       Date:  2014-06-12       Impact factor: 1.444

Review 7.  Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.

Authors:  Ruth Dobson; Gavin Giovannoni
Journal:  J Neurol       Date:  2013-01-12       Impact factor: 4.849

8.  Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study.

Authors:  Ali Manouchehrinia; Laura J Edwards; Homayoun Roshanisefat; Christopher R Tench; Cris S Constantinescu
Journal:  BMJ Open       Date:  2015-05-20       Impact factor: 2.692

9.  Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.

Authors:  Kishore Malyavantham; Bianca Weinstock-Guttman; Lakshmanan Suresh; Robert Zivadinov; Thomas Shanahan; Darlene Badgett; Murali Ramanathan
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

10.  Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors.

Authors:  Vladeta Ajdacic-Gross; Nina Steinemann; Gábor Horváth; Stephanie Rodgers; Marco Kaufmann; Yanhua Xu; Christian P Kamm; Jürg Kesselring; Zina-Mary Manjaly; Chiara Zecca; Pasquale Calabrese; Milo A Puhan; Viktor von Wyl
Journal:  Front Neurol       Date:  2021-07-06       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.